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ABSTRACT
THE EFFECT OF DOSAGE REGIMEN
ON MEDICATION COMPLIANCE
BY:

ERNEST W.

According to recent data,

KEICH

between 25% and 50%

of patients are noncompliant in their therapy regimen
in some manner.

The fourth report of the Joint National

Committee on the Detection,
High Blood Pressure

(Neal,

Evaluation,
1989)

and Treatment of

states that noncompliance

is the major problem in hypertension control.
It was hypothesized there would be a difference in
the compliance of hypertensive patients whose medication
regimen consisted of single daily dosing as opposed to
those patients whose regimen consisted of two or more
times a day dosing.
Potential subjects for the study were hypertensive
patients selected from a rural,

southeastern Georgia

setting who patronized a local pharmacy.
records from January 1,

The pharmacy's

1989 through October 15,

1991

were

accessed to identify patients prescribed only antihypertensive therapy and whose therapy had been consistent for
at least fourteen months.

Fifty-five subjects met this

criteria.
A data collection form was developed so that infor¬
mation from pharmaceutical records
iv

(computerized and

printed patient profiles)
standardized manner.

could be obtained in a

The form consisted of

twelve questions which addressed demographics,
of medication,

physician information,

types

payor type,

and

medication therapy.
From the information obtained,
between ten variables

(age,

race,

payor type,

marital status,

children,

gender,

class of medication,

medication regimen)

the relationship
town of residence,

whether subject had

physician setting,

and compliance percentage was analyzed.

Analysis of data was accomplished by univariate and multivariate analysis of variance

(ANOVA)

to test for signifi¬

cant differences between compliance percentage and the
factors of interest for the study.
Dosage regimen
times a day)

(once a day versus two or more

was the only statistically significant

factor related to compliance percentage.

v

INTRODUCTION

The problem of patient compliance in drug therapy
continues to be a major concern for healthcare providers,
and the subject of much research.

Much of this research

centers around the effects of noncompliance in antihypertensive therapy.

This noncompliance hinders effective

treatment by physicians often needlessly prolonging the
time necessary to stabilize the blood pressure of patients.
The lack of compliance has also resulted in otherwise un¬
necessary hospital admissions due to complications of unmanaged hypertension
& Sullivan,

(Chan,

Larsen,

Laventurier,

Strandberg,

1989).

Noncompliance in the treatment of hypertension is
a multi-faceted problem.

Up to 30% of prescriptions

written for antihypertensives are never filled.

Many

patients fail to have their prescriptions refilled on
time.

Often follow-up appointments with physicians are

never kept.

Most hypertensive patients average 3.6 pre¬

scriptions which they must administer themselves.

This

multi-drug therapy may lead to confusion and memory lapse
resulting in medications being taken improperly

(Redder,

1990).
All of the above offer an opportunity to hinder
medication compliance.

Perhaps the most effective aspect

that would improve this compliance would be to simpli-

2

fy drug therapy.
in two ways:
products,

Simplification could be accomplished

First,

through the use of combination

if a patient is now taking two separate

blood pressure medications,

perhaps he could be pre¬

scribed a product which combines the two drugs,

thereby

reducing the total number of medications consumed;
second,

by reducing the number of daily doses of medication,

if possible offering a regimen of once a day dosing rather
than more frequent daily dosing.
PURPOSE
The purpose of this study was to investigate the
effect of a once a day medication dosage regimen as
opposed to more frequent daily dosing on the compliance
of hypertensive patients.

The compliance percentages for

hypertensive patients were calculated and the relationship
of dosage regimens examined.
SIGNIFICANCE
Uncontrolled hypertension can have severe health
complications.

These complications can manifest them¬

selves in the form of coronary disease,
cular accidents

cerebral vas¬

(commonly called strokes),

myocardial

infarction,

or other ischemic diseases.

Among the black

population,

hypertension is primarily responsible for

their high mortality rates from heart and kidney disease
and stroke

(Coleman,

1990).

Improper medication administration has been shown

3

to prolong illness and contribute to hospitalization.
Concerning hospitalization,

Chan et al

(1989)

reported

that the ratio of days without antihypertensive drugs was
significantly higher in a re-admit group of patients
as compared with a no re-admit group of patients.
At a time when the nation is alarmed at the rocketing
costs of health care,

especially hospitalization;

the ex¬

ploration of every avenue to enhance favorable patient
outcomes has gained importance.
antihypertensive drugs,

With the advent of potent

noncompliance has become the most

limiting factor in the management of hypertension
& Vetter,

(Luscher

1 990 ) .
HYPOTHESIS

There is a statistically significant difference in
the mean compliance percentage of hypertensive patients
whose medication regimens consist of once a day dosing
as opposed to those patients whose regimens consist of
more frequent daily dosing.
DEFINITIONS
(1) Compliance

the extent to which a patient ob¬

tained from the pharmacy his medication as
scheduled.
(2) Dosage regimen

the prescribed medications,

their routes of administration,

and their

dosage frequencies as indicated for an individ¬
ual's course of therapy.

(3) Combination medication

a compound containing

two or more antihypertensive medications in a
single dosage form.
(4) Compliance percentage

refers to the percentage

obtained by dividing the number of pills or dosage
forms the customer purchased during the time
period of study by the number of pills prescribed
by the physician during the time period of study.
For patients on more than one antihypertensive
medication,

the medication having the lowest

compliance will be used in determining this
percentage.
ASSUMPTIONS
The study assumed that the number of pills bought
by patients was equal to the number of pills they con¬
sumed.

The assumption was also made that the patients

frequented only the pharmacy chosen for the study as their
single source of prescription medications.
LIMITATIONS
The study had several limitations,

primarily result¬

ing from the information available on the pharmaceutical
records.

The importance placed on the physician's influence

by each patient was not measured.

The amount of health

knowledge possessed by each patient was not determined.

5

The amount of family support and encouragement was not
measured.

The patient's understanding of his regimen was

not accessed;

nor was the impact of side effects on the

patient's adherence to his medication regimen.
Additional limitations included:

the lack of in¬

formation on the patient's marital adjustment;

the lack

of a mechanism to determine if the physician may
have given the patient oral instructions different from
the written prescription;

and the lack of sufficient age

data so as to be able to determine the impact this
variable had on the resulting compliance percentages.
The cost of the medication and whether or not the
patient properly monitored his blood pressure also were
not assessed.

6

CHAPTER 2

LITERATURE REVIEW

The lack of drug compliance is recognized by health¬
care practioners as a major health problem.

The degree

and extent to which this problem manifests itself has been
the subject of many research efforts.

This type of research

has proven to be difficult due to the numerous definitions
used for the term "compliance" by the various investigators
(Luscher,

Siegenthaler,

H. Vetter,

& W.

Vetter,

1985).

In a recent work reviewing fourteen studies on
medication compliance,

Luscher,

et.

al.

(1985)

reported

that twelve different definitions for compliance were
utilized.

Two studies used "mean compliance rate" as their

definition of compliance and two studies defined compliance
as greater than 80% of pills taken.

Results of these

studies yeilded compliance percentages ranging from 19%
to 87%.

The lack of standardization of definition for

compliance might explain some of the differences found
in these studies.
Although there is no firmly established definition
for compliance,

researchers have spent much effort in

determining factors which contribute to non-compliance.
These factors range from psychological and personal choice
behaviors to drug therapy and treatment specific aspects.
Seventeen studies were reviewed to determine factors
associated with compliance percentage.

The relationship

7

of the following factors and their impact on medication
compliance was explored.
Although the amount of "physician influence" was
mentioned as a factor related to compliance
Cadoret,

Troughton,

& Widmer,

1983),

1989;

no empirical data

was presented to support this relationship.
however,

(Neal,

Anecdotally,

many patients will comply with their regimen only

if encouraged by their physician (Neal,

1989).

Overall health knowledge of the patient is
another factor considered related to compliance.

However,

review of the literature revealed relatively little sup¬
port for a strong correlation between the two (Klein,
1988)

and no statistical data was presented for Klein's

study.
How well the patient understands his medication
regimen was discussed as a contributing factor in com¬
pliance.

The Virginia affiliate of The American Heart

Association surveyed 425 physicians as to why they felt
some of their patients did not adequately control their
hypertension.

The lack of understanding of medication

regimen by the patient was the major reason given in 82%
of the cases of uncontrolled hypertension

(Moore,

1988).

Studies also concentrated on patient education and
compliance counseling.
Kamachi,

and Kirk

(1985)

Black,

Elden,

Geary,

Hovell,

found an increase from 60% to

8

100% in compliance percentage after patient counseling.
Moore

(1988)

found that frequent blood pressure monitor¬

ing improved compliance in some patients.

This study

recommended company sponsored blood pressure monitoring
in the work place.
Physician setting was mentioned as having an
affect on compliance,

but only in a single study which

did not present statistical data

(Neal,

1989).

This

study found that patients seeing physicians in private
settings demonstrated better compliance than those seeing
physicians in clinic settings.
In 1990,

Groff,

Jono,

Trevino and Young reported a

relationship between marital adjustment and remembering
to take blood pressure medication.

They used a 32-item

Dyadic Adjustment Scale to measure the subject's per¬
ception of affection,
tion in marriage.

consensus,

cohesion and satisfac¬

This study supported the concept that

better marital adjustment does contribute to greater com¬
pliance with prescribed medical regimens.
The effect of the amount of family support has also
been found to be a determinant of medication compliance.
The extent to which the patient obtains support from
family members was stated as being directly related to
a patient's compliance

(Cadoret,

Troughton,

& Widmer,

1983).

9

However,

no statistical data relating to this factor was

presented.
An obvious reason for a patient being unable to
comply is the cost of medication.

Although cost was

discussed as a factor for compliance,

no statistical data

relating medication expense to compliance was presented
in a study by Fletcher

(1989).

Both age and side effects were also the focus of
research related to medication compliance.
in reviewing literature on compliance,
seldom considered in this research.

Interestingly,

age was a factor

Klein

(1988)

found

that the elderly patients try very hard to be compliant.
This study quoted two reports:

the Maryland Statewide

Hypertension Survey as reported by Entwisle,
Levine and Southard

(1984),

German,

Klein,

found that the patients most

likely to be actively taking their medication were the
elderly;

and a report from the National,

Blood Institute

(Haines & Ward,

1981)

Heart,

Lung,

and

which stated that,

"Younger hypertensives were more likely to discontinue
their medications than older ones".
Side effects were discussed in two studies as a
factor possibly impacting compliance;
were conflicting.

however,

the results

The first study was directed at how

physicians could improve their patients medication com¬
pliance.

In this study Moore,

(1988)

found that side

10

effects,

whether real or perceived,

are often a cause for

patients to discontinue their medication.
(1988)

However,

Klein

reported that the inverse relationship of compliance

and side effects was very weak and possibly of limited
clinical importance.
The effect of race and gender on medication com¬
pliance was considered.

Moore

(1988)

found that

inadequate hypertension control was most fequent in young
blacks and that a major factor contributing to this lack
of control was non-compliance with antihypertensive therapy.
Chan et al

(1989)

found in a study of underutilization

of antihypertensive drugs and associated hospital
re-admissions,
and Vetter

61% were black and 64% were female.

(1990)

Luscher

found that dropouts during antihyper¬

tensive therapy tended to be male and of low socioeconomic
status.

However,

this study also stated that patient

characteristics such as sex and race were unreliable
predictors of compliance with medication therapy.
Two additional factors affecting compliance appear¬
ed in more studies than any other.

The first was the

number of different medications taken by the patient.
The second was the number of times a day the patient had
to take each medication.

Much of the literature describing

these two factors stressed simplification of the patients
drug therapy.

It is strongly recommended that for increased

11

compliance,
if possible,
Nowson,

the medication therapy should be simple and,
a once-a-day dosing regimen

& Snowdon,

1986).

(Morgan,

Murphy,

Another recommendation is to

prescribe combination medications.

The combination

medications would enhance compliance by reducing the total
number of pills taken each day and because they are usually
less costly

(Moore,

1988).

As is evidenced,

the impact of non-compliance is great

both in terms of monetary and health costs.
tributory factors are many;
than others.

The con¬

some easier to manipulate

Prescribing a simpler dosage regimen

certainly appears to offer a measurable positive affect
on medication compliance.
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CHAPTER 3

METHODOLOGY

This study was an indepth case study of selected
hypertensive patients in an effort to determine the
relationship of drug regimen and medication compliance.
A twelve question data collection tool was developed
and utilized to record accumulated information of
medication purchases in a standardized manner.
The population consisted of hypertensive patients
receiving medications from a pharmacy in a rural setting.
The pharmacy was located in a town of approximately 2000
people.

There was not another pharmacy within an eight

mile radius of the one chosen for this investigation.

The

county and town were mid-to-lower economic areas with little
industrial development and were largely agriculturally based.
Since registered pharmacists have legal access
to patient records and are required by professional
ethics to maintain patient confidentiality,

there was

no need to obtain permission to review records from the
subjects.
1,

Printed and computerized profiles from January

1989 to October 15,

1991

were reviewed retrospectively

for all patients utilizing the pharmacy.
Hypertensive patients who met the following criteria
were selected as the sample for the study.

First,

that

they were taking only antihypertensive medications during

1 3

this study period.

This criteria implied that the patient

was taking a "pure" medication regimen
tions were prescribed).

Second,

(no other medica¬

that they were taking

the same regimen of antihypertensives for at least fourteen
months.

This second criteria implied the following:

that the patient's blood pressure was stablilized and
there was no need to change medication regimen,
patient was compliant,

that the

and the patient was experiencing

no significant side effects.
Each eligible patient was assigned an unique
indentification number which was used instead of a patient's
name on all data abstraction forms.

All information

relating the patient's name to his identification number
was destroyed;

thus,

ensuring confidentiality.

For each patient,

the principle researcher completed

a "Hypertensive Patient Data Collection Form"
appendix A).

Information was abstracted from the phar¬

macy's patient profiles.
following:
payor type

age,

gender,

(private,

This information included the
zip code,

medicaid,

regimen

race,

marital status,

third party,

whether the patient had children,
purchased,

(See

or other),

class of medication

physician setting (private or clinic),

(once a day,

times daily,

twice daily,

medication

three times daily,

five times daily or more),

four

medication name,

1 4

and compliance percentage.
The compliance percentage for each patient was
determined by dividing the number of pills that the
patient purchased over at least a fourteen month period
(the numerator)

by the number of pills that should

have been taken for the same time period as determined
by the recorded medication dosage regimen
ator).

(the denomi-

For patients on multiple hypertensive medications,

the medication having the lowest compliance
was used in determining this percentage.

This method

was selected since the most consistent a subject could
be in terms of medication compliance would be indicated
by their lowest compliance percentage.
The statistical technique used to test the study's
hypothesis was analysis of variance.

A one-way analy¬

sis of variance was used to assess the relationship of
compliance percentage and each categorical variable in¬
cluded in the study.

Comparisons were considered sig¬

nificantly different if a p-value of
puted.

For regimen,

.05 or less was com¬

a dichotomous variable was created:

1) Those patients who took their medications once daily;
2) Those who took their medications two or more times per
day.
A multivariable ANOVA model was constructed to test
the relationship between regimen and compliance when ad-

15
justing for race and gender.

These two variables were

associated with compliance rate in other studies
(Chan et al,

1 989) .
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CHAPTER 4

ANALYSIS AND FINDINGS

Fifty-five pharmacy patrons met the study's inclu¬
sion criteria.

Information abstracted for these subjects

utilizing the "Hypertensive Patient Data Collection Form"
(Appendix A)

was used for the analysis.

Statistical

analysis of the data was performed using the Statistical
Package for Social Science

(Norusis,

1988).

There were two continuous variables considered in
the study;

age and compliance percentage

the fifty five subjects,

(Table I).

For

age information was available

for eighteen patients only.

The mean age for these

eighteen patients was 60.78 years.

The mean compliance

percentage for the sample was 83.25%.

TABLE I
DESCRIPTION OF CONTINUOUS VARIABLES
OF SAMPLE

FACTOR

NUMBER

MEAN

STD.

DEV

Age(years)

18

60.78

13.49

Compliance
Percentage

55

83.25

17.75

Frequencies and percentages of the categorical
factors included in the study are reported in Table II.

TABLE II.
DESCRIPTION OF CATEGORICAL VARIABLES
OF SAMPLE
FACTOR NUMBER PERCENTAGE
Gender
a) Male 31 56.4
b) Female 24 4316
Town of Residence
a) Rincon 5
b) Springfield 26 4713
c) Guyton 13
23*fi
d) Eden 2
3*6
e) Clyo 7
,2\l
Missing data 2
3^5
Race
a) White 40 72.7
b) Black 14 25.5
Missing data 1
i^g
Marital Status
a) Married 42
b) Divorced 1
c) Widowed 10
Missing data 2

76.4
1.3
18.2
3.5

Payor Type
a) Private 46 83.6
b) Medicaid 1
1.3
c) Third party 3
5.5
d) Other 5
g.i
Has Children
a) Yes 48
b) No 5
Missing data 2

37.3
9.1
3,5

Class of Medication
a) Diuretic 3
5,5
b) Antiadrenergic 7
12.7
c) Calcium blocker 11 20.0
d) Ace-inhibitor 19 34.5
e) Combination 14 25.5
f) Other 1
1.8
Physician Setting
a) Private 49 89.1
b) Clinic 6
10.9
Medication Regimen
a) Once daily 33
b) Twice daily 18
c) Three times/day 3
d) Every other day 1

60.0
32.7
5,5
1.3

1 8
The sample was predominantly male
ried

(76.4%).

The majority (70.9%)

sided in two towns,
(72.7%)

(56.4%)

and mar¬

of the subjects re¬

Springfield and Guyton.

The majority

of the sample was white and had children (87.3%).

The sample was predominantly

(83.6%)

private pay and 80.0%

of the subjects received one of three classes of medication:
calcium channel blockers,
product.

The majority

ace-inhibitors or a combination

(89.1%)

of the patients saw

physicians in private settings and were on a once-a-day
medication regimen

(60.0%).

The results of one-way analysis of variance
are presented in Table III.

From this analysis,

(ANOVA)
the

only study factor to show a significant relationship in
effecting compliance percentage was medication regimen
(89.14 versus 74.6 mean percentage,

p= 0.0026).

In the multivariable ANOVA model which included com¬
pliance percentage

(dependent variable),

regimen,

race,

and gender;

regimen was again found to be statistically

significant

(p= 0.006).

a-day was 89.15,

The mean percentage for once

and the mean percentage for two or more

times a day was 75.05.

Race and gender were not signifi¬

cantly related to compliance percentage.

TABLE III.
UNIVARIATE ANALYSIS COMPARING MEAN
COMPLIANCE PERCENTAGE FOR SELECT STUDY FACTORS
FACTOR
Gender
a) Males
b) Females

NUMBER
31
24

MEAN

STD DEV

0.2550
80.83
86.37

20.15
13.86

Town of Residence
a) Rincon
5
b) Spring¬
field
26
c) Guyton
13
d) Eden
2
7
e) Clyo

79.64

32.27

82.52
82.64
93.90
84.11

17.57
16.46
4.67
14.68

Race
a) White
b) Black

40
14

83.30
84.36

19.00
14.16

Marital Status
a) Married
b) Divorced
c) Widowed

42
1
10

83.07
74.80
85.33

17.82
00.00
19.44

Payor Type
46
a) Private
1
b) Medicaid
3
c) Third pty.
5
d) Other

82.35
99.20
83.30
88.28

18.51
00.00
14.52
1 3.84

Has Children
a) Yes
b) No

48
5

82.08
95.48

18.25
4.61

Physician Setting
49
a) Private
6
b) Clinic

82.39
90.23

18.15
13.27

94.90

4.33

85.53

15.45

78.16

26.95

85.85

13.93

79.56
90.40

16.86
00.00

Class of
Medication
3
a) Diuretic
b) Antiadrenergic 7
c) Calcium
11
Blocker
d) Aceinhibitor 19
e) Combin¬
14
ation
1
f) other
Regimen
a) Once/day 33
b) 2 or more
times/day 21
* p <.05

PROBABILITY

0.9224

0.8490

0.8394

0.7338

0.1107

0.3118

0.6438

,0026*
89.1 4

11.12

74.60

22.56
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DISCUSSION AND CONCLUSIONS

This study was unique in the selective nature of the
sample.

No other research that was reviewed included

patients taking only antihypertensive medications or
required the subjects to remain on the same antihypertensiv
medication regimen for an extended period of time,

such

as fourteen months.
The implications resulting from this criteria were
that the subjects'

medication regimens were "pure"

were not taking other medications);
blood pressures were stabilized,
to change medication regimens;

(they

that the subjects'

thus there was no need

that the subjects were

experiencing no significant side effects;

and that they

were for the most part compliant.
These implications suggest a very specific population
which may affect generalizability of the study results.
However,

this select study sample enhances the internal

validity of the results in a way no other study has to
date.

Specifically,

compliant group,

in showing that within this highly

once-a-day regimens showed significantly

higher compliance than two or more times a day regimens.
Based on the information presented in this study,
the impact of dosage regimen on compliance percentage
is apparent.

Those patients whose regimen consists of

21

once a day therapy had a significantly higher
compliance percentage

(89.14%)

(p=0.0026)

than those patients taking

the medications two or more times a day (74.6%).

This

relationship also held after adjusting for age and gender.
The mean compliance percentages found in this study com¬
pared closely to those found in similar studies.
Troughton,

and Widmer

(1983)

Cadoret,

found a mean compliance

percentage of 87.5% for patients taking medications once
or twice a day and 78% for patients taking medications
three or four times a day.
This study supports efforts to educate physicians
to utilize newer antihypertensive medications which are
taken once a day.

It should be noted that 40% of the

subjects in this study were on a more than once-a-day
regimen.

If patients can be switched to once-a-day

medication and safely stabilized,

then better compliance

should be attained and ultimately lead to more effective
blood pressure control.
Although this study did show a significant rela¬
tionship between compliance percentage and regimen,

the

small size of the sample may have diminished statistical
importance of other study factors.
the source of information,

In addition,

pharmacy patient profiles,

lacked data for certain variables.

These missing data

included health knowledge of subject,
ing of his medication regimen,

patient's understand¬

patient's marital adjustment,

22

whether the subject properly monitored his blood pressure,
and if the physician may have given the patient oral
instructions different from the written prescription.
No statement of their impact on compliance percentage in
this study can be offered.
The assessment of the effect of age on compliance
was also limited in the study because of the sparsity of
data.

However,

a univariate ANOVA model

(n=18)

examining compliance rate and age found no significant
relationship between these two variables.

Other authors

stated that the elderly were more compliant (Klein,

1988).

Further research is indicated on the possible relation¬
ships of other factors

(side effects,

cost of medications,

and patient's understanding of regimen)
on compliance percentage,

and their affect

not only to produce new findings

but also to add support to the findings of this study.

23
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HYPERTENSIVE PATIENT DATA COLLECTION
FORM
1.

I.D. #

2.

Birthdate:

Month

Day

3. Gender (Circle):

Year

(1 - male, 2 - female)

4. Zip Code
5. Race (Circle):

(1 - white, 2 - black, 3 - asian,
4 - hispanic, 5 - other)

6. Martial Status (Circle):

(1 - married, 2 - single,
3 - divorced, 4 - widowed)

7. Payor Type (Circle):

(1 - private, 2 - medicaid,
3 - third party, 4 - other)

8. Children (Circle):

(1 - yes, 2 - no)

9. Medication Class (Circle):

(1- diuretic, 2- antiadrenergic,
3- calcium channel blocker,
4- ACE-inhibitor, 5-vasodilator
6- combination, 7- other)

10. Physician's name:
11. Physician's practice setting (Circle):

12. a) Regimen #1
medication name
date began
#times/day
#dosages/adminis.
date discontinued
# of dosages should
have taken
# of dosages
actually taken

(1- private 2- clinic)

Drug #1 Drug #2 Drug #3

Regimen #2

Drug #l

Drug #2

Drug #3

medication name
date began
#times/day
ttdosages/adminis.
date discontinued
# of dosages should
have taken
# of dosages
actually taken

Regimen #3

Drug #1 Drug #2 Drug #3

medication name
date began
#times/day
ttdosages/adminis.
date discontinued
# of dosages should
have taken
# of dosages
actually taken
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Abstract
According to recent data between 25% and 50% of
Patients are noncompliant in their therapy regimen in
in some manner.

The purpose of this study was to determine

the relationship of the frequency of daily doses and
medication compliance of hypertensive patients.

The sub¬

jects of the study were fifty-five patients who were pre¬
scribed only antihypertensive therapy and whose therapy
had been consistent for at least fourteen months.

Pharmacy

records were accessed to determine the compliance of these
subjects.

Patients on a once-a-day regimen demonstrated

a statistically significant

(p= 0.0026)

different mean

compliance percentage of 89.14% compared to a mean com¬
pliance percentage of 74.6% for those on a two or more
times a day regimen.
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INTRODUCTION
The problem of patient compliance in drug therapy
continues to be a major concern for healthcare providers,
and the subject of much research.

Much of this research

centers around the effects of noncompliance in antihypertensive therapy.

Noncompliance hinders effective treat¬

ment by physicians,

often needlessly prolonging the

time necessary to stabilize the blood pressure of patients.
Lack of compliance has also resulted in otherwise unneces¬
sary hospital admissions due to complications of unmanaged
hypertension

(1).

Noncompliance in the treatment of hypertension is
a multi-faceted problem.

Up to 30% of prescriptions

written for antihypertensives are never filled.

Many

patients fail to have their prescriptions refilled on
time.

Often follow-up appointments with physicians are

never kept.

Most hypertensive patients average 3.6 pre¬

scriptions for different medications which they must
administer themselves.

This multi-drug therapy may lead

to confusion and memory lapse resulting in medications
being taken improperly

(2).

All of the above indicate that lack of medication
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compliance is a major hindrance to the treatment of hyper¬
tension.

Perhaps the most effective aspect that would

improve this compliance would be to simplify drug therapy.
Simplification could be accomplished in two ways.
through the use of combination products.

First,

If a patient

is now taking two separate blood pressure medications,
perhaps he could be prescribed a product which combines
the two drugs,

thereby reducing the total number of

medications consumed.

The second method of simplication

would be to reduce the number of daily doses of medication;
if possible offer a regimen of once a day dosing rather
than more frequent daily dosing.
The purpose of this study was to investigate the
effect of a once a day medication dosage regimen on the
compliance of hypertensive patients as opposed to more
frequent daily dosing.

The compliance percentages for

hypertensive patients were calculated by dividing the
number of pills purchased during the time period of study
by the number the number of pills prescribed by the
physician during the time period of study.

For patients

on more than one antihypertensive medication,
ation having the lowest compliance
ming this percentage.

the medic¬

was used in deter-

MEDICATION COMPLIANCE
5
Methods
The population consisted of hypertensive patients
receiving medications from a pharmacy in a rural setting.
The pharmacy was located in a town of approximately 2000
people.

There was not another pharmacy within a nine mile

radius of the one chosen for this investigation.

The county

and town were mid-to-lower economic areas with little
industrial development and largely agriculturally based.
Hypertensive patients who met the following criteria
were selected as the sample for the study.

First,

that

they were taking only antihypertensive medications during
this study period.

This criteria implied that the patient

was taking a "pure" medication regimen
tions were prescribed).

Second,

(no other medica¬

that they were taking

the same regimen of antihypertensives for at least fourteen
months.

This second criteria implied the following:

that the patient's blood pressure was stablilized and
there was no need to change medication regimen,
patient was compliant,

that the

and the patient was experiencing

no significant side effects.

Based on these requirements,

fifty-five patients were included in the study.

Each

patient was assigned an unique indentification number which
was used instead of a patient's name on all data abstraction
forms.

All information relating the patient's name to
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his identification number was destroyed;

thus,

ensuring

confidentiality.
Since registered pharmacists have legal access
to patient records and are required by professional
ethics to maintain patient confidentiality,

there was

no need to obtain permission to review records from the
subjects.
1,

Printed and computerized profiles from January

1989 to October 15,

1991

were reviewed retrospectively

for all patients patronizing the pharmacy.
A twelve question data collection tool was developed
and utilized to retrieve accumulated information of
medication purchases in a standardized manner.
patient,

For each

the principle researcher completed the

"Hypertensive Patient Data Collection Form".

Information

abstracted from the pharmacy's patient profiles included
the following:
payor type

age,

(private,

gender,

zip code,

medicaid,

third party,

whether the patient had children,
purchased,
regimen

race,

marital status,
or other),

class of medication

physician setting (private or clinic),

(once a day,

times daily,

twice daily,

medication

three times daily,

four

five times daily or more), medication name,

and compliance percentage.
The compliance percentage for each patient was
determined by dividing the number of pills that the
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psticnt purchased over at least a fourteen month period
by the number of pills that should have been taken for
the same time period as determined by the recorded
medication dosage regimen.
hypertensive medications,

For patients on multiple
the medication having the lowest

compliance was used in determining this percentage.

This

method was selected since the most consistent a subject
could be in terms of medication compliance would be
indicated by their lowest compliance percentage.
The statistical technique used to test the study's
hypothesis was analysis of variance.

A one-way analy¬

sis of variance was used to assess the relationship of
compliance percentage and each categorical variable in¬
cluded in the study.

Comparisons were considered sig¬

nificantly different if a p-value of
puted.

For regimen,

.05 or less was com¬

a dichotomous variable was created:

1) Those patients who took their medications once daily;
2) Those who took their medications two or more times per
day.
A multivariable ANOVA model was constructed to test
the relationship between regimen and compliance when ad¬
justing for race and gender.

These two variables were

commonly associated with compliance rate in other
studies

(1).
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Results
Statistieal analysis of the data was performed
using the Statistical Package for Social Science

(4).

Information abstracted for the fifty-five subjects
utilizing the "Hypertensive Patient Data Collection Form"
was used for the analysis.
There were two continuous variables considered in
the study;

age and compliance percentage

the fifty five subjects,

(Table I).

For

age information was available

for eighteen patients only.

The mean age for these

eighteen patients was 60.78 years.

The mean compliance

percentage for the sample was 83.25%.

TABLE I.
DESCRIPTION OF CONTINUOUS VARIABLES
OF SAMPLE

FACTOR

NUMBER

MEAN

STD. DEV.

Age(years)

18

60.78

1 3.49

Compliance
percentage

55

83.25

1 7.75

Frequencies and percentages of the categorical
factors included in the study are reported in Table II.
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TABLE II.
DESCRIPTION OF CATEGORICAL VARIABLES
OF SAMPLE
FACTOR NUMBER PERCENTAGE
Gender
a) Male 31
b) Female 24

56.4
43.6

Town of Residence
a) Town 1.
5
g. i
b) Town II.
26
47.3
c) Town III. 13
23 6
d) Town IV. 2
gjg
e) Town V.
7
12]7
Missing data 2
3.5
Race
a) White 40
b) Black 14
Missing data 1

72.7
25.5
1.3

Marital Status
a) Married 42
b) Divorced 1
c) Widowed 10
Missing data 2

76.4
1.3
18.2
3.6

Payor Type
a) Private 46 83.6
b) Medicaid 1
1.3
c) Third party 3
5.5
d) Other 5
9.1
Has Children
a) Yes 48
b) No 5
Missing data 2

37.3
9.1
3.6

Class of Medication
a) Diuretic 3
5.5
b) Antiadrenergic 7
12.7
c) Calcium blocker 11 20.0
d) Ace-inhibitor 19 34.5
e) Combination 14 25.5
f) Other 1
1.8
Physician Setting
a) Private 49 89.1
b) Clinic 6 10.9
Medication Regimen
a) Once daily 33 60.0
b) Twice daily 18 32.7
c) Three times/day 3
5.5
d) Every other day 1
1«8
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The sample was predominantly male
ried

(76.4%).

The majority

sided in two towns.

(70.9%)

The majority

was white and had children
predominantly (83.6%)

(56.4%)

of the subjects re¬

(72.7%)

(87.3%).

of the sample

The sample was

private pay and 80.0% of the subjects

received one of three classes of medication:
channel blockers,
product.

and mar¬

calcium

ace-inhibitors or a combination

The majority (89.1%)

of the patients saw

physicians in private settings and were on a once-a-day
medication regimen

(60.0%).

The results of one-way analysis of variance
are presented in Table III.

From this analysis,

(ANOVA)
the

only study factor to show a significant relationship in
effecting compliance percentage was medication regimen
(89.1

versus 74.6 mean percentage at a p = 0.0026).
In the multivariable ANOVA model which adjusted for

race and gender,

regimen was again found to be significant¬

ly different at p= 0.006

(89.15 mean percentage for once-

a-day versus 75.05 mean percentage for two or more times
a day).
Discussion
This study was unique in the selective nature of the
sample.

No other research reviewed considered patients

taking only antihypertensive medications or required the
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TABLE HI.
UNIVARIATE ANALYSIS COMPARING MEAN
COMPLIANCE PERCENTAGE FOR SELECT STUDY FACTORS
FACTOR
Gender
a) Males
b) Females
Town
a)
b)
c)
d)
e)

NUMBER

MEAN

STD DEV

0.2550

31
24

80.83
86.37

20.15
13.86

of Residence
Town I.
5
Town II.
26
Town III.
13
Town IV.
2
7
Town V.

79.64
82.52
82.64
93.90
84.11

32.27
17.57
16.46
4.67
14.68

0.9224

Race
a) White
b) Black

40
14

83.30
84.36

19.00
14.16

Marital Status
a) Married
b) Divorced
c) Widowed

42
1
10

83.07
74.80
85.33

17.82
00.00
19.44

Payor Type
46
a) Private
1
b) Medicaid
3
c) Third pty.
5
d) Other

82.35
99.20
83.30
88.28

18.51
00.00
14.52
13.84

Has Children
a) Yes
b) No

48
5

82.08
95.48

18.25
4.61

Physician Setting
49
a) Private
6
b) Clinic

82.39
90.23

18.15
13.27

94.90

4.33

85.53

15.45

78.16

26.95

85.85

13.93

79.56
90.40

16.86
00.00

Class of
Medication
3
a) Diuretic
b) Antiadrenergic 7
c) Calcium
11
Blocker
d) Aceinhibitor 19
e) Combin¬
14
ation
1
f) other
Regimen
a) Once/day 33
b) 2 or more
times/day 21
* p <.05

PROBABILITY

0.8490

0.8394

0.7338

0.1107

0.3118

0.6438

.0026*

89.14

11.12

74.60

22.56
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subjects to remain on the same antihypertensive medication
regimen for an extended period of time such as fourteen
months.
The implications resulting from this criteria were
that the subjects'

medication regimens were "pure"

were not taking other prescription medications);
the subjects'

(they

that

blood pressures were stabilized thus there

was no need to change medication regimens;

that the

subjects were experiencing no significant side effects;
and that they were compliant.
These implications suggest a very specific population
which may affect generalizability of the study results.
However,

this select study sample enhances the internal

validity of the results in a way no other study has to
date.

Specifically,

groups,

in showing that within highly compliant

once-a-day regimens showed significantly higher

compliance than two or more times a day regimens.
Based on the information presented in this study,
the impact of dosage regimen on compliance percentage
is apparent.

Those patients whose regimen consists of

once a day therapy had a significantly higher
compliance percentage

(89.14%)

(p=0.0026)

than those patients taking

the medications two or more times a day (74.6%).

This

relationship also held after adjusting for age and gender.
The mean compliance percentages found in this study com-
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pared closely to those found in similar studies.
Troughton,

and Widmer(5)

Cadoret,

found a mean compliance

percentage of 87.5% for patients taking medications once
or twice a day and 78% for patients taking medications
three or four times a day.
This study supports efforts to educate physicians
to utilize newer antihypertensive medications which are
taken once a day.

It should be noted that 40% of the

subjects in this study were on a more than once-a-day
regimen.

If patients can be switched to once-a-day

medication and safely stabilized,

then they should ex¬

perience better compliance which would lead to more ef¬
fective blood pressure control.
Although this study did show a significant rela¬
tionship between compliance percentage and regimen,

the

small size of the sample may have diminished statistical
differences between other study factors.
the source of information,

In addition,

pharmacy patient profiles,

lacked data for certain variables.

These missing data

included health knowledge of subject,
ing of his medication regimen,

patient's understand¬

patient's marital adjustment,

whether the subject properly monitored his blood pressure,
and if the physician may have given the patient oral
instructions different from the written prescription.

MEDICATION COMPLIANCE
1 4
No statement of their impact on compliance percentage in
this study is founded.
The effect of age on compliance was also limited in
the study because of the sparsity of data.
univariate ANOVA model

(n=18)

However,

a

examing compliance rate and

age found no significant relationship between these two
variables.

Other authors stated that the elderly were

more compliant

(5).

Further research is indicated on the possible relation
ships of other factors

(side effects,

cost of medications,

and patient's understanding of regimen)
on compliance percentage,

and their affect

not only to produce new findings

but also to add support to the findings of this study.
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